Key Presentations of Celgene International Sárl Products to Be Highlighted at the 13th European Hematology Association Congress

BOUDRY, Switzerland--(BUSINESS WIRE)--Celgene International Sàrl (NASDAQ: CELG) today announced that clinical investigators from leading hematology research centers will present data from recent and on-going clinical trials of multiple Celgene products at the 13th European Hematology Association Congress in Copenhagen, Denmark from June 12 – 15, 2008. These presentations will highlight new efficacy and survival results, with important studies highlighting new health economic measures of Celgene therapies.
MORE ON THIS TOPIC